Ra Capital Management, L.P. Bellus Health Inc. Transaction History

Ra Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$7.14 - $8.53 $1.36 Million - $1.63 Million	191,000 Added 1.53%	12,643,574 $91 Million
Q4 2022 Feb 14, 2023	BUY	$8.22 - $10.76 $8.77 Million - $11.5 Million	1,067,000 Added 9.37%	12,452,574 $102 Million
Q3 2022 Nov 14, 2022	BUY	$8.95 - $12.0 $10.3 Million - $13.9 Million	1,155,300 Added 11.29%	11,385,574 $120 Million
Q4 2021 Feb 14, 2022	BUY	$5.26 - $8.3 $53.8 Million - $84.9 Million	10,230,274 New	10,230,274 $82.4 Million

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.